COMT and schizophrenia: Indeed, COMT polymorphism influences the severity of cognitive and behavioral symptoms in other diseases affecting subcortical DA regulation, such as Parkinson’s disease [18, 19] and schizophrenia [20], and is predictive of disease progression and psychosis in 22q11.2 deletion syndrome [21], another disease related to striatal dysfunction.